Marshall Wace, LLP Entera Bio Ltd. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Entera Bio Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 627,330 shares of ENTX stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
627,330Holding current value
$1.7 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENTX
# of Institutions
25Shares Held
9.21MCall Options Held
21.1KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$15.9 Million6.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.18MShares$3.19 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY567KShares$1.54 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT281KShares$761,0270.07% of portfolio
-
Northern Trust Corp Chicago, IL149KShares$402,8900.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $78.1M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...